A study of intima media thickness and their cardiovascular risk factors in patients with psoriatic arthritis

Sadhanah Aqashiah Mazlan1, Mohd Shahrir bin Mohamed Said, Heselynn Hussein

  • 1Hospital Ampang, Medical Department, Kuala Lumpur, Malaysia.

Acta Medica (Hradec Kralove)
|January 16, 2010
PubMed

Insights

Psoriatic arthritis patients show increased carotid intima media thickness, a marker of atherosclerosis. Age, hypertension, and metabolic syndrome are key predictors, not disease activity.

Area of Science:

  • Rheumatology
  • Cardiology
  • Vascular Ultrasound

Background:

  • Psoriatic arthritis (PsA) is an inflammatory condition linked to psoriasis.
  • Cardiovascular disease (CVD) risk in PsA patients requires further investigation.
  • Carotid intima media thickness (CIMT) is a sensitive indicator of subclinical atherosclerosis.

Purpose of the Study:

  • To determine the prevalence of CIMT in Malaysian PsA patients.
  • To identify associations between CIMT and disease activity or predictors.
  • To assess subclinical atherosclerosis in PsA.

Main Methods:

  • 63 PsA patients meeting CASPAR criteria were recruited.
  • High-resolution B-mode ultrasound measured common carotid intima media thickness (IMT).
  • A cross-sectional study design was employed.

Main Results:

  • 15.9% of PsA patients had positive IMT (>1.00 mm).
  • Significant associations found with age, waist circumference, hypertension, diabetes, and metabolic syndrome.
  • Age was the sole independent predictor of positive IMT (OR 1.116).

Conclusions:

  • CIMT is associated with cardiovascular risk factors in PsA patients.
  • No association was found between CIMT and PsA disease activity, severity, or DMARDs therapy.
  • This study highlights the importance of assessing cardiovascular risk in PsA.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...